14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.884 14 days ( 0.96 % )
Last Price $1.03 0.98 %
High/ Low $1.00 - $1.06 8.90%
Chg 7 Days 3.00 % $1.00 $1.03
Chg 30 Days -16.26 % $1.23 $1.03
Chg 12 mos -46.35 % $1.92 $1.03
Trend - 3 mos -4.26 % Width: 44.01 %
Trend - 12 mos -41.05 % Width: 223.32 %
Pred. range - 3 mos $0.90 - $1.30 -12.52 % - 25.98 %
Pred. range - 12 mos $0.214 - $0.693 -79.19 % - -32.71 %
Short MA avg 3 mos Buy Apr 25, 2024 - 8 days
Long MA avg 3 mos Sell Apr 08, 2024 - 21 days
Short/Long MA avg 3 mos Sell Apr 10, 2024 - 19 days
Short MA avg 12 mos Sell Apr 03, 2024 - 24 days
Long MA avg 12 mos Sell Apr 08, 2024 - 21 days
Short/Long MA avg 12 mos Sell Apr 19, 2024 - 12 days
Pivot Short Sell Apr 23, 2024 - 10 days
Bollinger Buy Feb 28, 2024 - 48 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Kronos Bio Inc.

Kronos Bio. Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The comp... KRON Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT